eltenac: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 51717 |
| CHEMBL ID | 2104561 |
| SCHEMBL ID | 145080 |
| MeSH ID | M0193510 |
| Synonym |
|---|
| eltenacum [latin] |
| eltenac |
| telzenac (tn) |
| D07888 |
| 72895-88-6 |
| eltenac (inn) |
| FT-0667838 |
| 2-[4-(2,6-dichloroanilino)thiophen-3-yl]acetic acid |
| unii-a153l3ja99 |
| 4-(2,6-dichloroanilino)-3-thiopheneacetic acid |
| eltenaco |
| a153l3ja99 , |
| eltenacum |
| eltenac [inn] |
| eltenaco [spanish] |
| telzenac |
| CHEMBL2104561 |
| eltenac [mart.] |
| 4-[(2,6-dichlorophenyl)amino]-3-thiopheneacetic acid |
| eltenac-13c,d3 |
| SCHEMBL145080 |
| DTXSID30223184 |
| AELILMBZWCGOSB-UHFFFAOYSA-N |
| 4-(2,6-dichloroanilino)-3-thiophenacetic acid |
| 3-thiopheneacetic acid, 4-[(2,6-dichlorophenyl)amino]- |
| CS-0024841 |
| 2-(4-((2,6-dichlorophenyl)amino)thiophen-3-yl)acetic acid |
| SB23043 |
| Q27273482 |
| HY-106093 |
| STARBLD0009574 |
| AKOS040748315 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "A double-blind study was performed, in horses, to determine the potential toxic effects of the nonsteroidal anti-inflammatory drug, eltenac(4-[(2,6-dichlorophenyl) amino]-3-thiopheneacetic acid)." | ( A toxicity study of eltenac, a nonsteroidal anti-inflammatory drug, in horses. Furr, MO; Goodrich, LR; Robertson, JL; Warnick, LD, 1998) | 0.83 |
Eltenac was administered IV at a dosage of 0.50 mg/ml. There was no clinically relevant accumulation of eltenac in equine plasma or alteration of pharmacokinetic variables after multiple IV dosing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To titrate a clinically effective eltenac dosage (0." | ( Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis. Hamm, D; Johnson, JC; Katz, T; Lockwood, PW; Thompson, KC; Turchi, P, 1997) | 0.85 |
| "Under conditions of this study, a dosage plateau for eltenac was determined (0." | ( Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis. Hamm, D; Johnson, JC; Katz, T; Lockwood, PW; Thompson, KC; Turchi, P, 1997) | 0.82 |
| "5 mg/kg), using a multiple dosing schedule." | ( Pharmacokinetics of multiple-dose administration of eltenac in horses. Ashcraft, SM; Dyke, TM; Sams, RA; Thompson, KG, 1998) | 0.55 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.27) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (33.33%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (66.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||